FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2025/11/097833 [Registered on: 21/11/2025] Trial Registered Prospectively
Last Modified On: 20/11/2025
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Ayurveda 
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   A Study To Comapre the Effects of Two Ayurvedic Medicine, Srikhandasava And Patolakaturohinyadi Kashaya, In adults with Alcoholic Fatty Liver Grade II for improving Liver health and Reducing Liver Fat. 
Scientific Title of Study   A Randomized, Controlled, Open-Label, Clinical Study To Evaluate The Efficacy Of Srikhandasava And Patolakaturohinyadi Kashaya In The Management Of Alcoholic Fatty Liver Grade II 
Trial Acronym  NIL 
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Dr Sunil Kumar 
Designation  Ph.D Scholar 
Affiliation  Shri Krishna Ayush University 
Address  Room No 69 Block 1 Department of Agad Tantra Shri Krishna Ayush University Umri Road Sector 8 Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  9569023573  
Fax    
Email  sunilbams20@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Dr Brijender Singh Tomar 
Designation  HOD and Professor 
Affiliation  Institute for Ayurved Studies and Research (Faculty of Ayurved) 
Address  Room No 69 Block 1 Department of Agad Tantra Shri Krishna Ayush University Umri Road Sector 8 Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  8950264121  
Fax    
Email  drbs_tomar@yahoo.co.in  
 
Details of Contact Person
Public Query
 
Name  Dr Sunil Kumar 
Designation  Ph.D Scholar 
Affiliation  Shri Krishna Ayush University 
Address  Room No 69 Block 1 Department of Agad Tantra Shri Krishna Ayush University Umri Road Sector 8 Kurukshetra

Kurukshetra
HARYANA
136118
India 
Phone  9569023573  
Fax    
Email  sunilbams20@gmail.com  
 
Source of Monetary or Material Support  
National College of Ayurveda and Hospital, Dhani Garan Road, Barwala, Hisar, Haryana 125121 
 
Primary Sponsor  
Name  Dr Sunil Kumar 
Address  Room No 69 Block 1 Department of Agad Tantra Shri Krishna Ayush University Umri Road Sector 8 Kurukshetra 
Type of Sponsor  Other [Self] 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Dr Sunil Kumar  National College of Ayurveda and Hopsital  Department of Agad Tantra, National College of Ayurveda and Hospital, Dhani Garan Road, Barwala
Hisar
HARYANA 
9569023573

sunilbams20@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
SKAU KURUKSHETRA IEC  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition:K700||Alcoholic fatty liver. Ayurveda Condition: YAKRUDDALYUDARAH,  
 
Intervention / Comparator Agent  
snoIntervention/ComparatorTypeDrug-TypeProcedure NameDetails
1Intervention ArmDrugClassical(1) Medicine Name: SRIKHANDASAVA, Reference: Bhaishajya Ratnavali Chapter 22, Route: Oral, Dosage Form: Asava, Dose: 24(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
2Comparator ArmDrugClassical(1) Medicine Name: PATOLAKATUROHINYADI KASHAYA, Reference: ASHTANGA HRIDAYA Chapter 15, Route: Oral, Dosage Form: Kwatha/ Kashaya, Dose: 24(ml), Frequency: bd, Bhaishajya Kal: Adhobhakta, Duration: 2 Months, anupAna/sahapAna: No, Additional Information: -
 
Inclusion Criteria  
Age From  21.00 Year(s)
Age To  50.00 Year(s)
Gender  Both 
Details  1. The patients between 21-50 years age
2. Patients with history of Alcoholic Fatty Liver Grade II
3. Patients with no known systemic disorders
4. Patients irrespective of sex, religion, socioeconomic status will be included.
5. Patients who are not under medication for any condition including ALDs
6. Patient with AUDIT score 16 and above.
7. In case of withdrawal of any participant new patient who fits to the above mentioned inclusion criteria will be included in the study for the completeness and accuracy of the data. 
 
ExclusionCriteria 
Details  1. Patients below 21 years of age and above 50 years of age
2. Patients suffering from other systemic disease that interfere with the prognosis and treatment of disease.
3. Patients suffering from any sort of fatal diseases.
4. Patients with the History of more than 5 years.
5. Patients with Non-alcoholic Fatty Liver (NAFLD).
6. Patients with Alcoholic Fatty Liver Grade I, Alcoholic Fatty Liver Grade III, Alcoholic Hepatitis, Cirrhosis, Liver Failure and any other liver diseases which is not caused by Alcoholic Fatty Liver Grade II.
7. The patients who are already under treatment for AFLD/NAFLD or were under the treatment for the above said conditions from any medical system till minimum two weeks prior to the conduct of the study. 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Not Applicable 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
The primary outcome of the study is the reduction in liver fat content and improvement in liver function in patients with Alcoholic Fatty Liver Grade II.  6 Months 
 
Secondary Outcome  
Outcome  TimePoints 
The secondary outcome focuses on the alleviation of symptoms and improvement in the quality of life of patients.  6 Months 
 
Target Sample Size   Total Sample Size="200"
Sample Size from India="200" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   Phase 3 
Date of First Enrollment (India)   01/12/2025 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="0"
Months="6"
Days="2" 
Recruitment Status of Trial (Global)   Not Yet Recruiting 
Recruitment Status of Trial (India)  Open to Recruitment 
Publication Details   N/A 
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  

This Study is randomized, controlled, open-label, clinical study to evaluate the efficacy of 24ml twice a day of srikhandasava and 24ml twice a day  of patolakaturohinyadi kashaya for 2 months in 200 patients with alcoholic fatty liver grade ii  that will be conducted in the IPD patients of National College of ayurveda and hospital, Barwala. The primary out come measure will be the reduction in liver fat content and improvement in liver function in patients with Alcoholic Fatty Liver Grade Il. The secondary outcome will be focuses on the alleviation of symptoms and improvement in the quality of life of patients.

 
Close